Новости

Что нового в Unlimited Bio

Анонсы исследований, конференции, партнёрства и упоминания в прессе.

June 11, 2026

Unlimited Bio Wins the Vitalist Bay Pitch Competition

Unlimited Bio took first place at the Vitalist Bay pitch competition, ahead of Frontier Bio and Sundial Therapeutics, in a lineup of frontier longevity and biotech startups.

May 20, 2026

VEGF now available on Bahamas

Unlimited Bio's VEGF gene therapy is now offered at GARM Bahamas Ltd., the newly opened flagship clinic at Hurricane Hole Marina on Paradise Island. Building on a 12-year legacy in regenerative medicine, GARM delivers world-class longevity care led by a d

March 28, 2026

Unlimited Bio CALM-AF-AI Trial Announcement

Unlimited Bio opens recruitment for CALM-AF-AI, a Phase 1/2a trial evaluating AAV9-Follistatin with or without VEGF gene therapy for age-related muscle decline.

March 3, 2026

Oliver Zolman MD joins Unlimited Bio XPRIZE Healthspan Team

Unlimited Bio and longevity physician Dr. Oliver Zolman partner to build a one-year, integrated rejuvenation protocol with measurable biomarkers—combining evidence-based lifestyle best practices with investigational therapeutics—to compete in XPRIZE

February 7, 2026

Dr. Anna Vakhrusheva joins Dr. Eric Verdin at the Longevity Biomarker Panel

Unlimited Bio participated in the Longevity Biomarkers Summit in Prospera, featuring Eric Verdin (Buck Institute) and discussions on biomarkers, pragmatic risk approaches, and responsible paths to faster healthspan innovation.

January 2, 2026

Сlarifications and Сontext for the MIT Technology Review article about Unlimited Bio

Clarifications on MIT Technology Review’s Unlimited Bio article: protocol details, small-n logic, and our safety/ethics stance on VEGF + Follistatin.

November 29, 2025

Unlimited Bio Represented at Global Longevity Summit Revive ME in Abu Dhabi

Unlimited Bio CEO Ivan Morgunov joined Revive ME 2025 in Abu Dhabi, presenting a fast-tracked combo-therapy approach to longevity and exploring partnerships across the longevity and healthtech ecosystem.

November 4, 2025

Unlimited Bio at the Free Cities Summit in Prague: Longevity as a Human Right

COO Vladimir Leshko represented Unlimited Bio at the Free Cities Conference 2025 in Prague (Oct 31–Nov 2), presenting “Próspera: The Path to Longevity as a Human Right” and connecting with the global Free Cities community.

September 15, 2025

Unlimited Bio COO Vladimir Leshko on the Emerging BioTech, MedTech & Web3 Ecosystem in Próspera

Unlimited Bio CEO Vladimir Leshko highlights Próspera’s rise as a global BioTech, MedTech & Web3 hub, Right-to-Try innovation, and investor momentum.

September 11, 2025

Longevity.Technology Spotlights Unlimited Bio’s Bold Gene Therapy Strategy

Longevity.Technology profiled Unlimited Bio, highlighting its VEGF therapy in Próspera, upcoming follistatin and combination trials, and a bold goal of 100 studies in 10 years, positioning the company as a fast-moving biotech innovator.

September 5, 2025

Unlimited Bio CTO Anna Vakhrusheva Shares Highlights from ARDD 2025 in Copenhagen

<strong>At ARDD 2025 in Copenhagen, Unlimited Bio CTO Anna Vakhrusheva highlighted A. Seluanov’s LINE1 retrotransposon research and bold hTERT biohacker experiments, underscoring ARDD’s role as a premier stage for longevity innovation.</strong>

August 26, 2025

Unlimited Bio Founders Join Dr. Matt Kaeberlein on Optispan Podcast

Dr. Matt Kaeberlein spoke with Unlimited Bio founders about the role of offshore clinics in accelerating gene therapies for aging. Unlimited Bio’s roadmap targets 100 clinical trials in 10 years using a combination therapy approach.

July 13, 2025

Unlimited Bio CTO Anna Vakhrusheva at RAADfest

At RAADfest 2025, Unlimited Bio CTO Anna Vakhrusheva emphasized that combination gene therapy offers the strongest path to extending healthy lifespan beyond 100 years.

June 16, 2025

Unlimited Bio COO Vladimir Leshko Presents Combination Gene Therapy at Genii Longevity Conference

At Genii Longevity Conference 2025 in Geneva, Unlimited Bio COO Vladimir Leshko presented the company’s Combination Gene Therapy strategy, stressing multi-target innovation, global expansion, and the need for new regulatory approaches.

June 2, 2025

Unlimited Bio at the U.S. Transhumanist Party Enlightenment Salon

COO Vladimir Leshko presented the Unlimited Bio plans to do human gene therapy combination trials vs aging

May 12, 2025

Unlimited Bio placed in the top 100 XPRIZE Healthspan teams

Unlimited Bio is thrilled to be among the Top 100 teams in the XPRIZE Healthspan contest, standing shoulder-to-shoulder with leading universities and public biotech companies.

May 11, 2025

Unlimited Bio Showcases Synergistic Gene Therapy Approach at Vitalist Bay

Unlimited Bio presents its multi-gene therapy strategy at Vitalist Bay, showing how combining VEGF, Follistatin, Klotho, and BDNF can enhance longevity outcomes.

May 11, 2025

Unlimited Bio COO Vladimir Leshko Explores the Intersection of Space and Longevity at “Health from Space” Conference

Unlimited Bio COO Vladimir Leshko discussed gene therapy for space health, regulatory sandboxes like Próspera, and the shared ambition of space and longevity innovation.

May 5, 2025

Pioneering Gene Therapy Cocktail Enters Mouse Trials at Unlimited Bio

A first-of-its-kind combinatorial gene therapy cocktail consisting of VEGF, Follistatin, Klotho, and BDNF is poised for mouse trials, marking an unprecedented advance in genetic medicine.

March 14, 2025

Unlimited Bio is on Meet the Drapers

Anna’s compelling pitch at “Meet the Drapers” reinforced Unlimited Bio’s vision and set the stage for our next big breakthrough.

February 19, 2025

Unlimited Bio Founders Featured on Infinita City Podcast with Niklas Anzinger

Niklas Anzinger, and the Unlimited Bio team discussed biotech cities, infinite-horizon investing, and flexible governance

February 14, 2025

Unlimited Bio Conducts VEGF Plasmid Gene Therapy Administration in Healthy Volunteers

On Feb 14, 2025, Unlimited Bio’s Tristan Roberts and Vladimir Leshko became the first healthy humans to receive VEGF plasmid gene therapy for vascular and muscle rejuvenation.

December 18, 2024

BioViva Partnership

Unlimited Bio to license AAV Gene therapies from BioViva

October 24, 2024

Unlimited Bio at Zelar City Summit: Exploring the Future of Longevity Science

Unlimited Bio COO Vladimir Leshko joined Zelar City Summit 2025 in Berlin to discuss organ replacement, gene therapy cocktails, and cryonics as pillars of human longevity.

May 13, 2024

Unlimited Bio Partners with Artgen Biotech to Advance VEGF Plasmid Gene Therapy

Unlimited Bio and Artgen Biotech join forces to explore VEGF plasmid gene therapy for cosmetic and regenerative uses, enhancing skin, muscle, and hair health.